| Name | Title | Contact Details |
|---|---|---|
Mike Tarpley |
Vice President and Chief Technology Officer | Profile |
Nashville Medical Group is a Nashville, TN-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Rehab Medical is a mobility equipment provider that specializes in Complex Rehab Technology (CRT). CRT is the configuration of mobility equipment that requires custom fitting, design, adjustment, and programming to meet the unique needs of each patient. Rehab Medical strives to improve lives through CRT with its team of experienced assistive technology professionals (ATPs) who utilize innovative technology to help patients regain their independence. Since the company was founded in 2005, Rehab Medical has helped more than 100,000 people regain their independence through wheelchairs and has emerged as a national leader of complex rehab technology within the United States.
M H Monteal Biotechnologies is a Kirkland, QC-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Medi-Globe Corporation is a Tempe, AZ-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Glaukos Corporation is an ophthalmic medical technology company focused on the development and commercialization of breakthrough products and procedures to transform the treatment of glaucoma, one of the world`s leading causes of blindness. Glaukos has pioneered Micro-Invasive Glaucoma Surgery, or MIGS, to revolutionize the traditional glaucoma treatment and management paradigm. The company launched the iStent Trabecular Micro-Bypass Stent, its first MIGS device, in the United States in 2012. Glaukos is leveraging its platform technology to build a comprehensive and proprietary portfolio of injectable micro-scale therapies designed to address the complete range of glaucoma disease states and progression. Glaukos believes the iStent is the smallest medical device ever approved by the Food and Drug Administration, or FDA, measuring 1.0 mm long and 0.33 mm wide. In June 2015, the company completed an initial public offering and its shares are now traded on the New York Stock Exchange under the ticker symbol "GKOS". Founded in 1998, Glaukos is based in San Clemente, California.